Morning Briefing

Immunizations can be a cost-effective means of disease prevention, but "[t]o reach the fully realized stage of cost-effectiveness, ... it is vital to acknowledge -- and more importantly, address -- the barriers that often prevent them from either being as cheap or as widely used as needed," Forbes contributor Sarika Bansal writes in a Forbes opinion piece. She cites costs associated with vaccines, such as shipping and refrigeration; time and monetary commitments from potential vaccine recipients; a lack of medical professionals in rural areas; and the implementation of public awareness campaigns as barriers to successful immunization campaigns.